Article No
155-90-225
NCBI Number | 959 |
Accession Number | P29965 |
Article No | 155-90-225 |
Country Availability | SE, FI, DK, NO, IS, EE, LV, LT, FO, GL |
Concentration | 0.1 mg/ml |
Description | CD40L multimeric Recombinant Protein |
Supplier | ProSci |
Entrez Gene ID | 27242,959 |
Format | Lyophilized |
Gene Symbol | CD40LG, TNFRSF21 |
Notes | MultimericCD40L™ is a high activity construct in which two trimeric CD40 ligands are artificially linked via the collagen domain of ACRP30. This construct very effectively simulates the natural membrane-assisted aggregation of CD40L in vivo. It provides a simple and equally potent alternative to [CD40L+enhancer] combinations. MultimericCD40L™ has shown to suppress alum-induced IL-1beta release and caspase-1 activation in a dose-, CD40- and time dependent manner, without affecting BMDM viability. It also effectively suppressed the inflammasome function triggered by NLRP3 activators. The secretion of caspase-1 independent inflammatory mediators has been shown to be unaltered or even enhanced. |
Alias Names | ACRP30headless:CD40L, ACRP30headless:CD154, ACRP30headless:TNFSF5, ADIPOQ-CD40L |
Previous Article No | 155-90-225-10 |
Product Type | Proteins & Peptides |
Protocol | This recombinant proteins is for research use only. |
Purity | >95% |
Research area | Cell Death |
Sequence | Human CD40L (aa 116-261) is fused at the N-terminus to mouse ACRP30headless (aa 18-111) and a DDDDK-tag. |
Shipping Information | RT |
Size | 10 ug |
Storage | -20°C |
Substrate / Buffer | Contains PBS Reconstitute with 100 μl sterile water. |
Technical Specifications | Induces B cells activation (as demonstrated by dose-dependent upregulation of CD86) (ED50: <1ng/ml). |
UniProt Number | O75509, P29965 |
Product Page Updated | 2024-01-03T13:34:25.701Z |